Abstract
Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-14 |
| Number of pages | 14 |
| Journal | Molecular Neurobiology |
| DOIs | |
| State | Accepted/In press - Apr 10 2018 |
Fingerprint
Keywords
- Amino acid metabolism
- Glucose
- Glucose transporters
- Lipid metabolism
- Metabolomics
- Neuron
ASJC Scopus subject areas
- Cellular and Molecular Neuroscience
Cite this
Impact of Hypoglycemia on Brain Metabolism During Diabetes. / Rehni, Ashish K.; Dave, Kunjan R.
In: Molecular Neurobiology, 10.04.2018, p. 1-14.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Impact of Hypoglycemia on Brain Metabolism During Diabetes
AU - Rehni, Ashish K.
AU - Dave, Kunjan R
PY - 2018/4/10
Y1 - 2018/4/10
N2 - Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.
AB - Diabetes is a metabolic disease afflicting millions of people worldwide. A substantial fraction of world’s total healthcare expenditure is spent on treating diabetes. Hypoglycemia is a serious consequence of anti-diabetic drug therapy, because it induces metabolic alterations in the brain. Metabolic alterations are one of the central mechanisms mediating hypoglycemia-related functional changes in the brain. Acute, chronic, and/or recurrent hypoglycemia modulate multiple metabolic pathways, and exposure to hypoglycemia increases consumption of alternate respiratory substrates such as ketone bodies, glycogen, and monocarboxylates in the brain. The aim of this review is to discuss hypoglycemia-induced metabolic alterations in the brain in glucose counterregulation, uptake, utilization and metabolism, cellular respiration, amino acid and lipid metabolism, and the significance of other sources of energy. The present review summarizes information on hypoglycemia-induced metabolic changes in the brain of diabetic and non-diabetic subjects and the manner in which they may affect brain function.
KW - Amino acid metabolism
KW - Glucose
KW - Glucose transporters
KW - Lipid metabolism
KW - Metabolomics
KW - Neuron
UR - http://www.scopus.com/inward/record.url?scp=85045139439&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045139439&partnerID=8YFLogxK
U2 - 10.1007/s12035-018-1044-6
DO - 10.1007/s12035-018-1044-6
M3 - Article
C2 - 29637442
AN - SCOPUS:85045139439
SP - 1
EP - 14
JO - Molecular Neurobiology
JF - Molecular Neurobiology
SN - 0893-7648
ER -